8792697

Source:http://linkedlifedata.com/resource/pubmed/id/8792697

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0050940, umls-concept:C0087111, umls-concept:C0205175, umls-concept:C0205250, umls-concept:C0850666, umls-concept:C1704419, umls-concept:C1880198
pubmed:issue	9
pubmed:dateCreated	1996-10-17
pubmed:abstractText	We have advocated quadruple therapy as the optimal therapy for cure of Helicobacter pylori infection. In this study, we investigated the efficacy and tolerability of 4-day therapy with lansoprazole, bismuth, tetracycline, and metronidazole.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0421030
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/2-Pyridinylmethylsulfinylbenzimidazo..., http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/Bismuth, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/H( )-K( )-Exchanging ATPase, http://linkedlifedata.com/resource/pubmed/chemical/Metronidazole, http://linkedlifedata.com/resource/pubmed/chemical/Omeprazole, http://linkedlifedata.com/resource/pubmed/chemical/Organometallic Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Tetracycline, http://linkedlifedata.com/resource/pubmed/chemical/bismuth tripotassium dicitrate, http://linkedlifedata.com/resource/pubmed/chemical/lansoprazole
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	0002-9270
pubmed:author	pubmed-author:OuwehandM EME, pubmed-author:SchadeR WRW, pubmed-author:SchneebergerP MPM, pubmed-author:TytgatG NGN, pubmed-author:de BoerW AWA, pubmed-author:van EttenR JRJ
pubmed:issnType	Print
pubmed:volume	91
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1778-82
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:8792697-2-Pyridinylmethylsulfinylbenzimidazoles, pubmed-meshheading:8792697-Anti-Bacterial Agents, pubmed-meshheading:8792697-Bismuth, pubmed-meshheading:8792697-Drug Therapy, Combination, pubmed-meshheading:8792697-Duodenal Ulcer, pubmed-meshheading:8792697-Enzyme Inhibitors, pubmed-meshheading:8792697-Female, pubmed-meshheading:8792697-H(+)-K(+)-Exchanging ATPase, pubmed-meshheading:8792697-Helicobacter Infections, pubmed-meshheading:8792697-Helicobacter pylori, pubmed-meshheading:8792697-Humans, pubmed-meshheading:8792697-Male, pubmed-meshheading:8792697-Metronidazole, pubmed-meshheading:8792697-Middle Aged, pubmed-meshheading:8792697-Omeprazole, pubmed-meshheading:8792697-Organometallic Compounds, pubmed-meshheading:8792697-Premedication, pubmed-meshheading:8792697-Prospective Studies, pubmed-meshheading:8792697-Tetracycline, pubmed-meshheading:8792697-Time Factors
pubmed:year	1996
pubmed:articleTitle	4-day lansoprazole quadruple therapy: a highly effective cure for Helicobacter pylori infection.
pubmed:affiliation	Department of Internal Medicine, Sint Anna Hospital, Oss, The Netherlands.
pubmed:publicationType	Journal Article, Clinical Trial